HER2/Neu cancer vaccine

US10052370B2 · kind B2 · utility

Assignees

• Icon Genetics GmbH · DE
• UNIVERSITY OF SOUTHAMPTON · GB

Inventors

• Natalia Savelyeva · Southampton, GB
• Franziska Jarczowski · Röblingen am See, DE
• Romy Kandzia · Bodenwerder, DE
• Anja Nickstadt · Bodenwerder, DE
• Frank Thieme · Halle (Saale), DE
• Victor Klimyuk · Leipzig, DE
• Yuri Gleba · Berlin, DE
• Duc Bui-Minh · Wien, AT
• Freda Stevenson · Southampton, GB
• Warayut Chotprakaikiat · Southampton, GB

Key dates

• Filing date: Mar 11, 2014
• Grant date: Aug 21, 2018
• Expiry date: Apr 11, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Y207/10001
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Protein conjugate comprising a protein antigen for generating an immune response against the HER2/neu protein and an immunogenic carrier covalently bonded to said protein antigen, wherein said protein antigen